The Scientific Research and Development team at Ixaka focuses on advancing the company's proprietary cell and gene therapy technologies. This team conducts cutting-edge research to enhance the therapeutic power of cells, develop targeted nanoparticles, and refine methods for modifying cells within the body. Their efforts support the treatment of serious diseases, including cancer, cardiovascular, neurological, and ocular disorders, as well as genetic conditions. Key areas of expertise within the team include chemistry, biology, polymer science, microfluidics, analytical development, and manufacturing processes.